Compare HQI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HQI | STXS |
|---|---|---|
| Founded | 2002 | 1990 |
| Country | United States | United States |
| Employees | 75000 | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 164.1M |
| IPO Year | 2008 | 2004 |
| Metric | HQI | STXS |
|---|---|---|
| Price | $13.79 | $1.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $13.00 | $4.00 |
| AVG Volume (30 Days) | 7.2K | ★ 1.1M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 73.08 | 16.67 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $30,640,000.00 | $29,346,617.00 |
| Revenue This Year | N/A | $28.22 |
| Revenue Next Year | $0.46 | $30.47 |
| P/E Ratio | $117.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.38 | $1.28 |
| 52 Week High | $14.54 | $3.59 |
| Indicator | HQI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 28.51 |
| Support Level | $12.03 | N/A |
| Resistance Level | $14.54 | $1.97 |
| Average True Range (ATR) | 0.41 | 0.13 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 90.24 | 7.50 |
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.